SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech funding rounds in 2024

TailorMed raises $40 million in equity and debt to help patients access critical medications

Why Israeli tech companies are moving to Miami

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

Buzz

Most popular

Daily

Weekly

1

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

2

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

3

Claroty veterans launch Twine with $12M in Seed funding from Dell and Wiz founders to deploy AI cyber workers

4

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

5

Prompt Security raises $18 million Series A to protect enterprises from GenAI risks

Tourette Syndrome

1 stories about Tourette Syndrome

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday